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 TRANSCRANIAL SONOGRAPHY OF BRAIN 
PARENCHYMA IN NEURODEGENERATIVE DISORDERS
Uwe Walter
University of Rostock, Department of Neurology
Transcranial B-mode sonography (TCS) is a non-invasive, low-cost, short-duration neuroimaging meth-
od that allows high-resolution imaging of deep brain structures in patients with movement disorders. With 
contemporary high-end ultrasound systems, image resolution of echogenic deep brain structures can even be 
higher on TCS than on MRI. On TCS, about 90% of patients with idiopathic Parkinson’s disease (PD) exhibit 
abnormal hyperechogenicity of the substantia nigra (SN). Th is fi nding is already present in presymptomatic 
disease stages, suggesting TCS as a screening tool for populations at risk of later developing PD. Meanwhile, a 
number of independent TCS studies have shown that SN hyperechogenicity well discriminates PD from other 
Parkinsonian disorders such as multiple-system atrophy, vascular Parkinsonism and welding-related Parkin-
sonism. In turn, normal SN echogenicity in combination with lenticular nucleus hyperechogenicity indicates 
an atypical Parkinsonian syndrome rather than PD with a specifi city and positive predictive value of more 
than 95%. TCS detects characteristic basal ganglia changes also in other movement disorders such as lenticular 
nucleus hyperechogenicity in idiopathic dystonia and Wilson’s disease and caudate nucleus hyperechogenicity 
in Huntington’s disease. Th e TCS fi nding of reduced echogenicity of midbrain raphe is frequent in depressive 
disorders and was found to correlate with responsivity to serotonin reuptake inhibitors. Emerging applications 
of TCS are the intra- and postoperative localization of deep brain stimulation electrodes in patients with move-
ment disorders, the detection of changes of deep brain structures in multiple sclerosis patients that may have 
a predictive value for further disease progression, as well as the characterisation of basal ganglia alterations in 
children with neurobehavioral disorders. 
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